189 related articles for article (PubMed ID: 18691855)
1. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
[TBL] [Abstract][Full Text] [Related]
2. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
[TBL] [Abstract][Full Text] [Related]
5. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
[TBL] [Abstract][Full Text] [Related]
6. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
Schneider S; Uchida K; Brabender J; Baldus SE; Yochim J; Danenberg KD; Salonga D; Chen P; Tsao-Wei D; Groshen S; Hoelscher AH; Schneider PM; Danenberg PV
J Am Coll Surg; 2005 Mar; 200(3):336-44. PubMed ID: 15737843
[TBL] [Abstract][Full Text] [Related]
8. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality.
Bitzer M; Stahl M; Arjumand J; Rees M; Klump B; Heep H; Gabbert HE; Sarbia M
Anticancer Res; 2003; 23(2B):1489-93. PubMed ID: 12820414
[TBL] [Abstract][Full Text] [Related]
9. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
Hu M; Liu Q; Song P; Zhan X; Luo M; Liu C; Yang D; Cai Y; Zhang F; Jiang F; Zhang Y; Tang M; Zuo G; Zhou L; Luo J; Shi Q; Weng Y
Oncol Rep; 2013 Jan; 29(1):185-92. PubMed ID: 23128493
[TBL] [Abstract][Full Text] [Related]
11. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
[TBL] [Abstract][Full Text] [Related]
13. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
Yamasaki M; Miyata H; Fujiwara Y; Takiguchi S; Nakajima K; Nishida T; Yasuda T; Matsuyama J; Mori M; Doki Y
Ann Surg Oncol; 2010 Feb; 17(2):634-42. PubMed ID: 19941080
[TBL] [Abstract][Full Text] [Related]
14. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
Wang XS; Liu MZ; Zhang CQ; Cai L; Cui NJ
Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915
[TBL] [Abstract][Full Text] [Related]
15. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers.
Takahashi T; Haruki N; Nomoto S; Masuda A; Saji S; Osada H; Takahashi T
Oncogene; 1999 Jul; 18(30):4295-300. PubMed ID: 10439037
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.
Wada N; Yoshida A; Miyagi Y; Yamamoto T; Nakayama H; Suganuma N; Matsuzu K; Masudo K; Hirakawa S; Rino Y; Masuda M; Imada T
Anticancer Res; 2008; 28(1A):139-44. PubMed ID: 18383837
[TBL] [Abstract][Full Text] [Related]
17. Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma.
Hsieh PC; Chen YK; Tsai KB; Shieh TY; Chang YY; Chang JG; Wu HL; Lin SF
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):257-67. PubMed ID: 19926498
[TBL] [Abstract][Full Text] [Related]
18. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
[TBL] [Abstract][Full Text] [Related]
19. High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.
Warnecke-Eberz U; Metzger R; Miyazono F; Baldus SE; Neiss S; Brabender J; Schaefer H; Doerfler W; Bollschweiler E; Dienes HP; Mueller RP; Danenberg PV; Hoelscher AH; Schneider PM
Clin Cancer Res; 2004 Jun; 10(11):3794-9. PubMed ID: 15173087
[TBL] [Abstract][Full Text] [Related]
20. VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients.
Sakaeda T; Yamamori M; Kuwahara A; Hiroe S; Nakamura T; Okumura K; Okuno T; Miki I; Chayahara N; Okamura N; Tamura T
Ther Drug Monit; 2008 Aug; 30(4):497-503. PubMed ID: 18641541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]